Insider Transactions in Q1 2024 at Adaptive Biotechnologies Corp (ADPT)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 12
2024
|
Peter M Neupert Director |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+8.14%
|
$0
$0.84 P/Share
|
|
Mar 05
2024
|
Chad M Robins CEO and Chairman |
SELL
Open market or private sale
|
Direct |
48,673
-0.93%
|
$146,019
$3.44 P/Share
|
|
Mar 05
2024
|
Tycho Peterson Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
15,456
-2.83%
|
$46,368
$3.44 P/Share
|
|
Mar 05
2024
|
Julie Rubinstein President |
SELL
Open market or private sale
|
Direct |
39,070
-3.89%
|
$117,210
$3.5 P/Share
|
|
Mar 05
2024
|
Sharon Benzeno Chief Commercial Ofc Imm Med |
SELL
Open market or private sale
|
Direct |
29,390
-4.2%
|
$88,170
$3.44 P/Share
|
|
Mar 05
2024
|
Francis Lo Chief People Officer |
SELL
Open market or private sale
|
Direct |
14,700
-2.76%
|
$44,100
$3.44 P/Share
|
|
Mar 05
2024
|
Stacy L Taylor SVP and General Counsel |
SELL
Open market or private sale
|
Direct |
13,381
-3.8%
|
$40,143
$3.44 P/Share
|
|
Mar 05
2024
|
Kyle Piskel Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
7,727
-5.9%
|
$23,181
$3.43 P/Share
|
|
Mar 05
2024
|
Susan Bobulsky Chief Commercial Officer, MRD |
SELL
Open market or private sale
|
Direct |
12,991
-2.52%
|
$38,973
$3.44 P/Share
|
|
Mar 04
2024
|
Robert Hershberg Director |
BUY
Grant, award, or other acquisition
|
Direct |
31,328
+22.6%
|
-
|
|
Mar 04
2024
|
Peter M Neupert Director |
BUY
Grant, award, or other acquisition
|
Direct |
31,328
+16.88%
|
-
|
|
Mar 04
2024
|
Katey Einterz Owen Director |
BUY
Grant, award, or other acquisition
|
Direct |
31,328
+35.37%
|
-
|
|
Mar 04
2024
|
Michael J Pellini Director |
BUY
Grant, award, or other acquisition
|
Direct |
31,328
+36.59%
|
-
|
|
Mar 04
2024
|
Chad M Robins CEO and Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
354,610
+11.9%
|
-
|
|
Mar 04
2024
|
Tycho Peterson Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
147,790
+21.27%
|
-
|
|
Mar 04
2024
|
Harlan S Robins Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
354,610
+25.78%
|
-
|
|
Mar 04
2024
|
Julie Rubinstein President |
BUY
Grant, award, or other acquisition
|
Direct |
175,000
+25.48%
|
-
|
|
Mar 04
2024
|
Sharon Benzeno Chief Commercial Ofc Imm Med |
BUY
Grant, award, or other acquisition
|
Direct |
132,979
+27.15%
|
-
|
|
Mar 04
2024
|
Francis Lo Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
99,976
+27.14%
|
-
|
|
Mar 04
2024
|
Stacy L Taylor SVP and General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
39,990
+18.21%
|
-
|
|
Mar 04
2024
|
Kyle Piskel Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
43,740
+25.03%
|
-
|
|
Mar 04
2024
|
Michelle Renee Griffin Director |
BUY
Grant, award, or other acquisition
|
Direct |
31,328
+37.62%
|
-
|
|
Mar 04
2024
|
Susan Bobulsky Chief Commercial Officer, MRD |
BUY
Grant, award, or other acquisition
|
Direct |
132,979
+33.73%
|
-
|